Atorvastatin delays progression of pancreatic lesions to carcinoma by regulating PI3/AKT signaling in p48Cre/+ LSL-KrasG12D/+ mice

Elevated myeloid-derived suppressor cells in pancreatic, esophageal and gastric cancer are an independent prognostic factor and are associated with significant elevation of the Th2 cytokine interleukin-13

(2011) Rachel F. Gabitass et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Inhibition of chronic pancreatitis and pancreatic intraepithelial neoplasia (PanIN) by capsaicin in LSL-KrasG12D/Pdx1-Cre mice

(2011) H. Bai et al.   CARCINOGENESIS

The Epidermal Growth Factor Receptor Inhibitor Gefitinib Prevents the Progression of Pancreatic Lesions to Carcinoma in a Conditional LSL-KrasG12D/+ Transgenic Mouse Model

(2010) A. Mohammed et al.   Cancer Prevention Research

Pitavastatin inhibits azoxymethane-induced colonic preneoplastic lesions in C57BL/KsJ-db/db obese mice

(2010) Yoichi Yasuda et al.   CANCER SCIENCE

Statins inhibit Akt/PKB signaling via P2X7 receptor in pancreatic cancer cells

(2009) Oras Mistafa et al.   BIOCHEMICAL PHARMACOLOGY

The angiotensin-I-converting enzyme inhibitor enalapril and aspirin delay progression of pancreatic intraepithelial neoplasia and cancer formation in a genetically engineered mouse model of pancreatic cancer

(2009) V. Fendrich et al.   GUT

Caveolin-1 mediated radioresistance of 3D grown pancreatic cancer cells

(2009) Stephanie Hehlgans et al.   RADIOTHERAPY AND ONCOLOGY